epidemiology in cancer
TRANSCRIPT
-
8/11/2019 Epidemiology in Cancer
1/35
Epidemiology in Cancer
-
8/11/2019 Epidemiology in Cancer
2/35
Picture of Cells Nucleus
-
8/11/2019 Epidemiology in Cancer
3/35
-
8/11/2019 Epidemiology in Cancer
4/35
-
8/11/2019 Epidemiology in Cancer
5/35
-
8/11/2019 Epidemiology in Cancer
6/35
Make a metaphase
or interphase
spread
Identify and line up
each chromosome
pairs side by side
Look for structure
abnormalities
Picture of Chromosomes
-
8/11/2019 Epidemiology in Cancer
7/35
Chromosomes comes in Pair one
from dad and one from mom
-
8/11/2019 Epidemiology in Cancer
8/35
-
8/11/2019 Epidemiology in Cancer
9/35
-
8/11/2019 Epidemiology in Cancer
10/35
-
8/11/2019 Epidemiology in Cancer
11/35
-
8/11/2019 Epidemiology in Cancer
12/35
opr05TIB.swf
http://localhost/var/www/apps/conversion/tmp/scratch_8/opr05TIB.swfhttp://localhost/var/www/apps/conversion/tmp/scratch_8/opr05TIB.swf -
8/11/2019 Epidemiology in Cancer
13/35
-
8/11/2019 Epidemiology in Cancer
14/35
-
8/11/2019 Epidemiology in Cancer
15/35
-
8/11/2019 Epidemiology in Cancer
16/35
-
8/11/2019 Epidemiology in Cancer
17/35
-
8/11/2019 Epidemiology in Cancer
18/35
-
8/11/2019 Epidemiology in Cancer
19/35
-
8/11/2019 Epidemiology in Cancer
20/35
Knudsen Two Hits Hypothesis
-
8/11/2019 Epidemiology in Cancer
21/35
Oncogenesis
Statistic based predictionRetinoblastoma is genotypically recessive,only manifest when both Rb gene copies aremutated ie genotype is rb/rb, carrier (i.g.RB/rb) are normal
Descendents from a carrier and a normal
parent theoritically should be 0% forRetinoblastoma
Observation
50% of the children develop
Retinoblastoma
Two Steps (Hits) Oncogenesis
Introduction
-
8/11/2019 Epidemiology in Cancer
22/35
OncogenesisTwo Steps (Hits) Oncogenesis
Introduction
Genotype Clinical
Children
Tumor
Germline
Somatic
0%RB?
50%RB!
2 Hits : Germline inactivating mutation in previous
generation + somatic inactivating mutation in tumor
RB/rb
RB/rb
RB/RB
RB/RB
rb/rb
-
8/11/2019 Epidemiology in Cancer
23/35
Is all cancer one genic?
Nope
-
8/11/2019 Epidemiology in Cancer
24/35
Multistep oncogenesis Pathway
-
8/11/2019 Epidemiology in Cancer
25/35
-
8/11/2019 Epidemiology in Cancer
26/35
Animation of Oncogenesis
..\My Documents\pasca\S2-FIK\immunitas
kanker\grows.swf
..\My Documents\pasca\S2-FIK\immunitas
kanker\breastcancer.swf
http://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/breastcancer.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swfhttp://localhost/var/www/apps/conversion/tmp/My%20Documents/pasca/S2-FIK/immunitas%20kanker/grows.swf -
8/11/2019 Epidemiology in Cancer
27/35
-
8/11/2019 Epidemiology in Cancer
28/35
Rate of genomic Mutations is low
So how is it possible to get cancer if
-
8/11/2019 Epidemiology in Cancer
29/35
So how is it possible to get cancer if
there are too many pathways need to
be disrupted to generate one The persons genome need to be in a state
that is unstable. Easily mutating by
itself!!
= Genomic Instability
Or being mutated continuously from
outside = radiation exposure. Chernobylfor example
-
8/11/2019 Epidemiology in Cancer
30/35
-
8/11/2019 Epidemiology in Cancer
31/35
Pathways to malignancy
Genomic Instability Pathway
Barriers are the
two hits
TSG Recql4,
BLM, WRN
OG : any genes
that promote
genomic
instability
-
8/11/2019 Epidemiology in Cancer
32/35
-
8/11/2019 Epidemiology in Cancer
33/35
Epid Early detection: So who are
the predisposed group?
People with familial cancer history
Same type of cancer Breast cancer for BRAC1/2
Retinoblastoma MSI and APC for colonic Cancer
Different type of cancer P53
Req1lc Bloom Syndrome
Werner Syndrome
-
8/11/2019 Epidemiology in Cancer
34/35
What to do in the presence ofpredisposing factors?
Regular screening for progression genetic
abnormalities by cytogenetics.
Molecular genetics work up for critical genes in the
absence of cytogenetic evidence
- Southern Blot
- SSCP
Epigenetics work up in the absence of cytogenetic and
genetics evidence.
Regular Radiologic or bone scan work up
-
8/11/2019 Epidemiology in Cancer
35/35
Epidemiology in action